Professor Li Min is an expert in the treatment of neurodegenerative diseases by using Chinese medicine, a respected research scientist in the field of Autophagy, Chinese medicinal pharmacology in treating and prevention of Parkinson’s disease (PD), Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS). Currently, Professor Li holds these positions in the School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU): Associate Dean of SCM; Programme Director of Bachelor of Chinese Medicine & Bachelor of Science (Hons) in Biomedical Science; Director, Master of Chinese Medicine programme; and Director, Mr. and Mrs. Ko Chi Ming Centre for Parkinson's Disease Research (CPDR).

Professor Li obtained her Bachelor's degree in Chinese Medicine from Henan University of Traditional Chinese Medicine (TCM), China, in 1985, she also obtained MPhil degree in Chinese Medicine at the Guangzhou University of Chinese Medicine, China, in 1988 and obtained her PhD degree in Cardiology at the School of Medicine, Tokai University, Japan, in 2001. Professor Li joined the SCM, HKBU in 2001 as assistant professor, her research focuses on neurodegenerative diseases, including Parkinson's disease (PD), Alzheimer's disease (AD) and vascular dementia (VD), as well as on cardio-cerebrovascular disease and on related new drug discovery. For more information please refer to her lab: https://cpdr.hkbu.edu.hk

As of March 2023, Professor Li has registered over 20 patents, and presented and/or published over 400 papers in journals, books and international conferences. Based on her outstanding research and clinical experience, Prof. Li received an Award of the Distinguished Female Chinese Medicine Practitioner by the China Association of Chinese medicine in 2007, School's Award for Outstanding Performance in Scholarly Work in 2012 and President's Award for Outstanding Performance in Teaching from Hong Kong Baptist University in 2013 and 2018. Prof. Li's clinical specialty is in Chinese medicine treatment of neurodegenerative diseases, including Parkinson's disease (PD), Alzheimer's disease (AD) and vascular dementia (VD), as well as on Cardio-cerebrovascular diseases.

Prof. Li's long-term research interests are:

• Neurodegenerative diseases including Parkinson's Disease (PD) , Alzheimer's Disease (AD) and Amyotrophic Lateral Sclerosis (ALS).
• Traditional Chinese medicine (TCM) for prevention and treatment of neurodegenerative diseases.
• Development of molecular targets for new drug discovery from TCM for neurodegenerative diseases.

Prof. Li's current research directions are:

• Autophagy regulation in neurodegenerative diseases including  Alzheimer's disease (AD) , Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS).
• Understanding the neuroprotective effects and underlying mechanisms of TCM on neurodegenerative diseases including AD, PD and ALS.
• Investigation of the efficacy and safety of TCM in the treatment of neurodegenerative diseases including AD and PD based on randomized controlled clinical trials, as well as the interaction of TCM and Western medicine.